Polar buys stake in Mediwound

Polar Communications has invested NIS 9 million in Mediwound to acquire a 6% stake in the company.

By SETH FREEDMAN
May 10, 2006 07:34

Polar Communications has invested NIS 9 million in Mediwound to acquire a 6% stake in the company. Based in Yavne, Mediwound develops Debrase Gel Dressing for treating burns and is the exclusive licensee of two patents that cover the extraction and purification process of Debrase. It is currently completing Phase II/b clinical trials in burn centers in the EU and the US.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Israel Weather
  • 10 - 21
    Beer Sheva
    11 - 20
    Tel Aviv - Yafo
  • 9 - 16
    Jerusalem
    10 - 18
    Haifa
  • 15 - 25
    Elat
    12 - 22
    Tiberias